Dr. Luo was born in 1963. He has been working at Sun Yat-sen University Cancer Center after his graduation from the Department of Medicine at the former Sun Yat-sen University of Medical Sciences in 1987. He obtained his master's degree of medicine in 1995, and pursued further clinical study at radiation department of MD Anderson Cancer Center from 2004 to 2005. He is one of the cultivated talents from the Hundred, Thousand and Ten-Thousand Talent Project, an editorial board member of Chinese Journal of Neuro-Oncology, a peer reviewer of the Journal of Cancer Research and Therapeutics, a member of ASTRO, as well as a member of the medical malpractice appraisal library of Guangdong Medical Association and a member of the Guangzhou Medical Association. He specializes in radiotherapy and combination therapy of head and neck cancer, especially nasopharynx carcinoma.

Dr. Luo devotes his studies to improving external radiation techniques for nasopharynx carcinoma: improvement of body position and measures of fixation, two-dimensional Conformal Radiation Therapy and application of low-melting lead block. The results of such studis have been used in clinical practice, which has led to an increase in overall survival rates in 5 years for patients with nasopharynx carcinoma receiving initial treatment, raising from 50% in the 70s and 80s of the last century to about 70% in the middle and end of 90s of the last century and the beginning of this century. His studies mainly involve the following three areas in recent years: (1) conformal IMRT for nasopharynx carcinoma; (2) application of individualized oral stent of radiotherapy for head and neck cancer, demonstrating certain protective effects on the tongue and gustation of patients; (3) treatment of middle or advanced nasopharynx carcinoma with a new model of combining TPF induction chemotherapy and concurrent chemotherapy and radiotherapy, producing inspiring therapeutic effects.

Dr. Luo has devoted to studies of improving external radiation techniques for nasopharynx carcinoma: improvement of body position and measures of fixation, two-dimensional Conformal Radiation Therapy and application application of low-melting lead block, and etc. The results of such study has been used in clinical practice, which has led to an increase in overall survival rate in 5 years for patients with nasopharynx carcinoma receiving initial treatment, raising from 50% in the 70s to 80s of the last century to about 70% in the middle and end of 90s of the last century and the beginning of this century. His studies mainly involve the following three areas in recent years: (1) conformal IMRT for nasopharynx carcinoma; (2) application of individualized oral stent of radiotherapy for head and neck cancer, demonstrating certain protective effects on the tongue and gustation of patients; (3) treatment of middle or advanced nasopharynx carcinoma with a new model of combining TPF induction chemotherapy and concurrent chemotherapy and radiotherapy, producing inspiring therapeutic effects.

1987: Graduated from Department of Medicine, former Sun Yat-sen University of Medical Sciences
1995: Obtained Master of Medicine

Updated by International Office, Sun Yat-sen University Cancer Center